WHAT: RGI is to present “Rare Genomics Institute: Rare99X Clinical Exome Challenge” at the annual Partnering for Cures meeting in New York City on the 30th of November. It is one of 30 transformative, cross-sector collaborations featured in the Innovator Presentation track of the meeting.
The Rare99X Clinical Exome Challenge holds great potential to transform the way genome sequencing and exploration of rare diseases are currently being done by scientists and researchers.
WHO: Jimmy Lin, the founder of Rare Genomics Institute who received his MD/PhD from Johns Hopkins School of Medicine. He currently is a research instructor leading the clinical exome sequencing initiative in the Genomic & Pathology Services with Washington University in St. Louis.
WHEN: Partnering for Cures will be held November 28-30, 2012. The Rare99X Clinical Exome Challenge Presentation is scheduled for November 30th, from 10:15-10:40am.
WHERE: Grand Hyatt Hotel, New York City
BACKGROUND: Partnering for Cures brings together 800 leaders from all sectors of the medical research enterprise to speed up the time it takes to turn promising scientific discoveries into treatments. It is convened by FasterCures, a center of the Milken Institute.
In addition to the innovator presentations, the meeting features a stellar speaker line-up, including: NIH’s Francis Collins, FDA’s Janet Woodcock, QB3′s Regis Kelly, Arizona State University’s Anna Barker, Onyx Pharmaceuticals’ Anthony Coles, PureTech Ventures’ Ben Shapiro, the Michael J. Fox Foundation’s Todd Sherer, and many other leaders from industry, academia, finance, philanthropy, and government. Partnering for Cures also features a state-of-the-art partnering system that eases the process of networking and finding nontraditional allies.
For more information and to register, please visit www.partneringforcures.org.
For more information about RGI, contact:
Amanda Lordemann, Director of Media Relations. amanda.lordemann@raregenomics.org
For more information about Partnering for Cures and FasterCures, contact:
Cecilia Arradaza
Communications & Marketing Director, FasterCures
carradaza@fastercures.org